Investors pump another $8.8M into KC medical device startup, bringing funding total to $20M+ 

March 31, 2020  |  Startland News Staff

Nicholas Franano, Artio

A Fairway-based medical device company is getting to the heart of its entrepreneurial journey, securing a fresh $8.8 million in Series A financing, Dr. Nicholas Franano announced Tuesday.

The additional influx to Artio — rebranded from “Metactive” earlier this winter — brings the startup’s total capital raised to more than $20 million. The company has spent years developing groundbreaking, best-in-class products for the peripheral vascular and neurovascular markets, said Franano, founder, president and CEO of Artio.

“We appreciate the strong support from our new and existing investors,” he said. “Our team is looking forward to making our innovative products available to physicians and patients.”

Click here to see why Artio/Metactive was named one of Startland News’ Kansas City Startups to Watch in 2019.

Funds from the latest round are expected to help Artio obtain 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market its Solus Gold Embolization Device in the United States.

Solus Gold Embolization Device

The Solus Gold is the first metal implant to provide a solid barrier to blood flow, and is developed for peripheral vascular embolization — a minimally invasive procedure that blocks or reduces blood flow in blood vessels for patients experiencing life-threatening bleeding and other serious medical conditions.

The combination of a low-profile, flexible delivery system and a detachable gold metal implant is designed for passage through tortuous blood vessels, precision placement, and immediate vessel occlusion after placement of a single device, according to the company.

Franano’s team also has revealed two other next-gen embolization products, the Solus Flex device and Aneura system.

Click here to learn more about these peripheral vascular solutions.

“Artio is developing a strong portfolio of disruptive, next-generation peripheral vascular and neurovascular embolization products, and we were thrilled to help lead the latest round of funding,” said Nathaniel Hagedorn, founder and CEO of Northpoint Development. “I have been incredibly fortunate to have so many people help me build my business and am happy to ‘pay it forward’ to a fellow entrepreneur with a clear vision and accomplished team.”

startland-tip-jar

TIP JAR

Did you enjoy this post? Show your support by becoming a member or buying us a coffee.

Tagged , , , ,
Featured Business
    Featured Founder

      2020 Startups to Watch

        stats here

        Related Posts on Startland News

        Kansas City’s Top VC-Backed Companies in 2019

        By Tommy Felts | August 13, 2019

        The Top Venture Capital-Backed Companies List recognizes the momentum pushing an emerging cohort of Kansas City growth-stage, venture-backed companies.  Simply put, the list — updated and now published annually — shows a massive increase in venture capital deployed to Kansas City companies in 2019, as well as a significant jump in jobs at those businesses.…

        Project United Knowledge, Cohort 2

        Project UK banks $50K JPMorgan Chase Foundation investment via ‘united effort’ with UMKC Innovation Center

        By Tommy Felts | August 13, 2019

        A hefty infusion of funding is expected to help Project United Knowledge offer more tools to black, Latinx and other professionals from underrepresented groups, according to the UMKC Innovation Center.  The $50,000 investment from the JPMorgan Chase Foundation was awarded to the UMKC Innovation Center, which partners with Project UK to deliver programming, resources and…

        Clara Biotech boasts first-of-its-kind cancer detection from lab in Lawrence

        By Tommy Felts | August 13, 2019

        A Kansas startup says its cancer detection process — requiring only a single blood sample — could dramatically simplify a often-harrowing health care experience, as well as lead to personalized treatments for illnesses ranging from cancer to neurological diseases like Parkinson’s or multiple sclerosis.  Clara Biotech — based in Lawrence at the BioScience and Technology…

        OHUB Kansas City

        OHUB’s ‘unapologetic’ arrival in KC comes with $300K in support; ‘Cosby Show’ alum at Friday event

        By Tommy Felts | August 13, 2019

        A familiar face from pop culture and $300,000 in entrepreneurial support are just two highlights tied to the Opportunity Hub’s new effort to build a more inclusive startup ecosystem in Kansas City.   “Many times, [building an inclusive community] involves hosting a series of frequently held, branded events that introduce community stakeholders to black and Latinx…